Bristol-Myers Squibb has signed an agreement worth $475 million to develop a new form of cancer immunotherapy drug with US biotech Dragonfly Therapeutics. BMS is best known as an early pioneer of ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Long before birds ruled the skies, the dragonfly evolved a hunting strategy so effective ...

June 3 (Reuters) - Wildlife experts found eight new species of dragonfly, three unknown grasshoppers and some 60 new butterflies and moths in vivid hues during a trip to Angola's ‌Lisima plateau in ...

During his COMPUTEX 2026 keynote in Taipei, Qualcomm CEO Cristiano Amon introduced Dragonfly, a new brand that will cover the company’s future data center products. That includes server CPUs, AI ...

Johns Hopkins Applied Physics Laboratory engineers Max Wolbeck and Daniel Peterson install rotors on a model of half the Dragonfly aircraft for testing. Credit: NASA The team has started assembling ...

In 2034 NASA scientists will be flying around Titan. Remotely, of course—Titan, Saturn’s largest moon, is more than a billion kilometers away from Earth, a journey no human can yet make. It’s also ...

Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. In this eMag, we try to establish agentic AI ...

Dragonfly Capital has closed a $650 million fourth fund, one of the largest recent crypto venture capital raises despite a prolonged industry downturn. Managing partner Haseeb Qureshi said the firm is ...

In sending a car-sized rotorcraft to explore Saturn's moon Titan, NASA's Dragonfly mission will undertake an unprecedented voyage of scientific discovery. And the work to ensure this first-of-its-kind ...

Here is a reason why Dragonfly owners are okay with waiting two years or more to get their hands on the new 36. Everyone that has tested it agrees: It’s a multihuller’s dream boat. “Exhilarating” is ...

AbbVie has scrapped an asset from its ongoing collaboration with Dragonfly Therapeutics, a spokesperson for the Chicago pharma confirmed to Fierce Biotech. “We have terminated clinical activity around ...